Sichuan Defeng Pharmaceutical is a national high-tech enterprise mainly engaged in drug R&D and production, and its products are mainly drugs for dermatological, gynecological, pediatric, orthopedic, cardio cerebrovascular diseases. The company produces 15 dosage forms, including granules, ointments, capsules and sprays, all of which have passed the GMP compliance on-site inspection. At present, the company has 82 drug registration certificates, including 15 national exclusive varieties (dosage forms). Its eight leading products including Dehumidifying and Antipruritic Ointment, Skin Allergy Relieving Capsules, Emedastine Difumarate Sustained-release Capsules and Oxytocin Nasal Spray have entered the new version of National Medical Insurance Reimbursement List, and Dehumidifying and Antipruritic Ointment has entered the National Essential Drugs List. The company has always adhered to the strategy of scientific innovation orientation. Relying on the strong technical background and powerful R&D team of Yifan Pharmaceutical, the company has gained approval for establishment of a provincial-level enterprise technology center, a city-level engineering technology center and other innovative R&D platforms. The company has been constantly increasing its R&D investment, which has generated remarkable R&D efficiency and outcomes. At present, the company has 33 domestic authorized patents, including 11 invention patents, 22 utility model patents and 1 international PCT patent.